Jay David Caplan

CIK: 0001419217

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (36.4%)

Position reduction

Option Exercises (M)4 (36.4%)

Derivative conversions

Awards (A)3 (27.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GUTS

FRACTYL HEALTH, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

GUTS
FRACTYL HEALTH, INC.
Dec 15, 2025
Award(A)
Stock Option (right to buy)
Direct
845.2K shares-
GUTS
FRACTYL HEALTH, INC.
Feb 27, 2025
Award(A)
Stock Option (right to buy)
Direct
179.7K shares-
GUTS
FRACTYL HEALTH, INC.
Feb 27, 2025
Award(A)
Stock Option (right to buy)
Direct
104.4K shares-
GUTS
FRACTYL HEALTH, INC.
Jan 31, 2025
Exercise(M)
Direct
22.3K shares at avg. $1.70$38K
GUTS
FRACTYL HEALTH, INC.
Jan 31, 2025
Sale(S)
Direct
22.3K shares at avg. $1.81$40K
GUTS
FRACTYL HEALTH, INC.
Jan 30, 2025
Exercise(M)
Direct
21.5K shares at avg. $1.70$37K
GUTS
FRACTYL HEALTH, INC.
Jan 30, 2025
Sale(S)
Direct
21.5K shares at avg. $1.95$42K
GUTS
FRACTYL HEALTH, INC.
Nov 11, 2024
Sale(S)
Direct
64.2K shares at avg. $2.47$159K
GUTS
FRACTYL HEALTH, INC.
Nov 10, 2024
Exercise(M)
Direct
187.3K shares-
GUTS
FRACTYL HEALTH, INC.
Sep 12, 2024
Sale(S)
Direct
65K shares at avg. $2.90$188K
GUTS
FRACTYL HEALTH, INC.
Sep 12, 2024
Exercise(M)
Direct
95.5K shares at avg. $1.70$162K

		Type	Shares	Price		Ownership
Dec 15, 2025	GUTS FRACTYL HEALTH, INC.	Award(A) Stock Option (right to buy)	845,226	-	-	Direct
Feb 27, 2025	GUTS FRACTYL HEALTH, INC.	Award(A) Stock Option (right to buy)	179,700	-	-	Direct
Feb 27, 2025	GUTS FRACTYL HEALTH, INC.	Award(A) Stock Option (right to buy)	104,400	-	-	Direct
Jan 31, 2025	GUTS FRACTYL HEALTH, INC.	Exercise(M)	22,346	$1.70	$37,988	Direct
Jan 31, 2025	GUTS FRACTYL HEALTH, INC.	Sale(S)	22,346	$1.81	$40,464	Direct
Jan 30, 2025	GUTS FRACTYL HEALTH, INC.	Exercise(M)	21,472	$1.70	$36,502	Direct
Jan 30, 2025	GUTS FRACTYL HEALTH, INC.	Sale(S)	21,472	$1.95	$41,802	Direct
Nov 11, 2024	GUTS FRACTYL HEALTH, INC.	Sale(S)	64,197	$2.47	$158,541	Direct
Nov 10, 2024	GUTS FRACTYL HEALTH, INC.	Exercise(M)	187,257	-	$0	Direct
Sep 12, 2024	GUTS FRACTYL HEALTH, INC.	Sale(S)	65,000	$2.90	$188,474	Direct
Sep 12, 2024	GUTS FRACTYL HEALTH, INC.	Exercise(M)	95,484	$1.70	$162,323	Direct

1-11 of 11 transactions

About Caplan Jay David

Caplan Jay David (SEC CIK 0001419217) files insider reports with the SEC as President, Chief Product Off. of FRACTYL HEALTH, INC. (GUTS).

Signal8 holds 5 ownership filings by Caplan Jay David, all Form 4s, filed between Sep 13, 2024 and Dec 17, 2025. Those filings report 11 transactions, from Sep 12, 2024 to Dec 15, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Caplan Jay David's filings is in BURLINGTON, MA.

Recent filings by Caplan Jay David

Dec 15, 2025: Grant or award of GUTS derivative securities (Form 4, code A).
Feb 27, 2025: Grants or awards of GUTS derivative securities (2 lines, Form 4, code A).
Jan 31, 2025: Option exercise of GUTS shares (Form 4, code M).
Jan 31, 2025: Open-market sale of GUTS shares (Form 4, code S).
Jan 30, 2025: Option exercise of GUTS shares (Form 4, code M).

Other insiders filing for FRACTYL HEALTH, INC. (GUTS)

BRADLEY WILLIAM, Director
Royan Ajay, Director
Conaway Samuel, Director
Thompson Christopher Charles, Director
Elia Marc, Director
Barnes Kelly Ann, Director

How to read Form 4 transaction codes